Zobrazeno 1 - 10
of 1 241
pro vyhledávání: '"Werb, Z"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Devignes, C.S. (1), Brenot, A. (2), Devillers, A. (1), Fabre, S. (1), Aslan, Y. (1), Schepers, K. (3), Chou, J. (2), Casbon, A.J. (2), Werb, Z. (2), Provot, S. (1)
Publikováno v:
In Revue du rhumatisme November 2016 83 Supplement 1:A103-A104
Autor:
Shahi, P, Wang, C-Y, Chou, J, Hagerling, C, Gonzalez Velozo, H, Ruderisch, A, Yu, Y, Lai, M-D, Werb, Z
Publikováno v:
Oncogene, vol 36, iss 40
Semaphorin 3B (SEMA3B) is a secreted axonal guidance molecule that is expressed during development and throughout adulthood. Recently, SEMA3B has emerged as a tumor suppressor in non-neuronal cells. Here, we show that SEMA3B is a direct target of GAT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::37a2df75339f0b4d40fbf171fae7008c
https://escholarship.org/uc/item/2xz6p07t
https://escholarship.org/uc/item/2xz6p07t
Autor:
Lawson, DA, Bhakta, NR, Kessenbrock, K, Prummel, KD, Yu, Y, Takai, K, Zhou, A, Eyob, H, Balakrishnan, S, Wang, CY, Yaswen, P, Goga, A, Werb, Z
Publikováno v:
Nature, vol 526, iss 7571
Lawson, DA; Bhakta, NR; Kessenbrock, K; Prummel, KD; Yu, Y; Takai, K; et al.(2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature, 526(7571), 131-135. doi: 10.1038/nature15260. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0x8772xv
Lawson, DA; Bhakta, NR; Kessenbrock, K; Prummel, KD; Yu, Y; Takai, K; et al.(2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature, 526(7571), 131-135. doi: 10.1038/nature15260. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0x8772xv
© 2015 Macmillan Publishers Limited. All rights reserved. Despite major advances in understanding the molecular and genetic basis of cancer, metastasis remains the cause of >90% of cancer-related mortality. Understanding metastasis initiation and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2806dbb37f0ee253311c903e75c51b85
https://escholarship.org/uc/item/0x8772xv
https://escholarship.org/uc/item/0x8772xv
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Kessenbrock, K; Wang, CY; Wang, CY; & Werb, Z. (2014). Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biology. doi: 10.1016/j.matbio.2015.01.022. UCSF: Retrieved from: http://www.escholarship.org/uc/item/9d95z2td
© 2015. Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this intriguing family of extracellular proteinases has been implicated in variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::87420dba9032689ce01b5468dfe7bcdf
http://www.escholarship.org/uc/item/9d95z2td
http://www.escholarship.org/uc/item/9d95z2td
Autor:
Horiuchi, D, Zhou, AY, Corella, AN, Yau, C, Lawson, DA, Bazarov, AV, Yaswen, P, McManus, MT, Welm, AL, Werb, Z, Goga, A
Publikováno v:
MOLECULAR CANCER THERAPEUTICS, vol 12, iss 11
Horiuchi, D; Zhou, AY; Corella, AN; Yau, C; Lawson, DA; Bazarov, AV; et al.(2013). PIM1 kinase is essential for the growth of MYC-overexpressing triple-negative breast tumors and is an efficacious therapeutic target. MOLECULAR CANCER THERAPEUTICS, 12(11). doi: 10.1158/1535-7163.TARG-13-B232. UCSF: Retrieved from: http://www.escholarship.org/uc/item/1pt500ts
Horiuchi, D; Zhou, AY; Corella, AN; Yau, C; Lawson, DA; Bazarov, AV; et al.(2013). PIM1 kinase is essential for the growth of MYC-overexpressing triple-negative breast tumors and is an efficacious therapeutic target. MOLECULAR CANCER THERAPEUTICS, 12(11). doi: 10.1158/1535-7163.TARG-13-B232. UCSF: Retrieved from: http://www.escholarship.org/uc/item/1pt500ts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3ba0f7b2682f836d409d862aaa564c3b
https://escholarship.org/uc/item/1pt500ts
https://escholarship.org/uc/item/1pt500ts
Autor:
Littlepage, LE, Adler, AS, Kouros-Mehr, H, Huang, G, Chou, J, Krig, SR, Griffi th, OL, Korkola, JE, Qu, K, Lawson, DA, Xue, Q, Sternlicht, MD, Dijkgraaf, GJP, Yaswen, P, Rugo, HS, Sweeney, CA, Collins, CC, Gray, JW, Chang, HY, Werb, Z
Publikováno v:
Cancer discovery, vol 2, iss 7
Littlepage, LE; Adler, AS; Kouros-Mehr, H; Huang, G; Chou, J; Krig, SR; et al.(2012). The transcription factor ZNF217 Is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discovery, 2(7), 638-651. doi: 10.1158/2159-8290.CD-12-0093. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7xs7c1z4
Littlepage, LE; Adler, AS; Kouros-Mehr, H; Huang, G; Chou, J; Krig, SR; et al.(2012). The transcription factor ZNF217 Is a prognostic biomarker and therapeutic target during breast cancer progression. Cancer Discovery, 2(7), 638-651. doi: 10.1158/2159-8290.CD-12-0093. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7xs7c1z4
The transcription factor ZNF217 is a candidate oncogene in the amplicon on chromosome 20q13 that occurs in 20% to 30% of primary human breast cancers and that correlates with poor prognosis. We show that Znf217 overexpression drives aberrant differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3836b58d04c39e978dd1b4997db9b4ea
https://escholarship.org/uc/item/7xs7c1z4
https://escholarship.org/uc/item/7xs7c1z4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.